Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wessels

Showing results (261-270 of 554) with videos related to

Pageof 56
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 19, 2012
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol usersT I Verhoef, W K Redekop, M M Buikema, et al.
Arthritis and Rheumatism|March 31, 2006
Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymesJudith A M Wessels, Jeska K de Vries-Bouwstra, Bas T Heijmans, et al.
British Journal of Clinical Pharmacology|June 24, 2016
Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipientsDirk Jan A R Moes, Rogier R Press, Oliver Ackaert, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task ForceD Angioni, J Cummings, C J Lansdall, et al.
Breast Cancer Research and Treatment|July 12, 2013
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trialV O Dezentjé, R H N van Schaik, J M Vletter-Bogaartz, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 1, 2021
Building clinically relevant outcomes across the Alzheimer's disease spectrumDorene M Rentz, Alette M Wessels, Ananth V Annapragada, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 13, 2020
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's diseaseAlette M Wessels, Christopher Lines, Robert A Stern, et al.
Pharmacogenomics|December 11, 2012
Evaluation of the effect of genetic variations in GATA-4 on the phenprocoumon and acenocoumarol maintenance doseRianne M F van Schie, Judith A M Wessels, Talitha I Verhoef, et al.
Breast Cancer Research and Treatment|November 23, 2013
CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trialVincent O Dezentjé, Hans Gelderblom, Ron H N Van Schaik, et al.
JAMA|July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical TrialJohn R Sims, Jennifer A Zimmer, Cynthia D Evans, et al.
Pageof 56

Showing results (261-270 of 554) with videos related to

Sort By:
Pageof 56
Journal of Thrombosis and Haemostasis : JTH|January 19, 2012
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol usersT I Verhoef, W K Redekop, M M Buikema, et al.
Arthritis and Rheumatism|March 31, 2006
Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymesJudith A M Wessels, Jeska K de Vries-Bouwstra, Bas T Heijmans, et al.
British Journal of Clinical Pharmacology|June 24, 2016
Exploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipientsDirk Jan A R Moes, Rogier R Press, Oliver Ackaert, et al.
The Journal of Prevention of Alzheimer'S Disease|October 1, 2024
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task ForceD Angioni, J Cummings, C J Lansdall, et al.
Breast Cancer Research and Treatment|July 12, 2013
CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trialV O Dezentjé, R H N van Schaik, J M Vletter-Bogaartz, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 1, 2021
Building clinically relevant outcomes across the Alzheimer's disease spectrumDorene M Rentz, Alette M Wessels, Ananth V Annapragada, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 13, 2020
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's diseaseAlette M Wessels, Christopher Lines, Robert A Stern, et al.
Pharmacogenomics|December 11, 2012
Evaluation of the effect of genetic variations in GATA-4 on the phenprocoumon and acenocoumarol maintenance doseRianne M F van Schie, Judith A M Wessels, Talitha I Verhoef, et al.
Breast Cancer Research and Treatment|November 23, 2013
CYP2D6 genotype in relation to hot flashes as tamoxifen side effect in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trialVincent O Dezentjé, Hans Gelderblom, Ron H N Van Schaik, et al.
JAMA|July 17, 2023
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical TrialJohn R Sims, Jennifer A Zimmer, Cynthia D Evans, et al.
Pageof 56